| Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity KS Chen, C Reinshagen, TA Van Schaik, F Rossignoli, P Borges, ... Science translational medicine 15 (677), eabo4778, 2023 | 21 | 2023 |
| Therapy-induced tumor cell death: friend or foe of immunotherapy? TA Van Schaik, KS Chen, K Shah Frontiers in Oncology 11, 678562, 2021 | 20 | 2021 |
| Gene-edited and-engineered stem cell platform drives immunotherapy for brain metastatic melanomas N Kanaya, Y Kitamura, M Lopez Vazquez, A Franco, KS Chen, ... Science translational medicine 15 (698), eade8732, 2023 | 4 | 2023 |
| Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors TA Van Schaik, L Moreno-Lama, TA Farzani, M Wang, KS Chen, W Li, ... Biomedicine & Pharmacotherapy 162, 114665, 2023 | 3 | 2023 |
| A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator A Zaalberg, E Minnee, I Mayayo-Peralta, K Schuurman, S Gregoricchio, ... bioRxiv, 2023 | 2 | 2023 |
| Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice L Liu, TA van Schaik, KS Chen, F Rossignoli, P Borges, V Vrbanac, ... Frontiers in Immunology 14, 1324618, 2024 | | 2024 |
| Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138 JJ van der Schans, Z Wang, J van Arkel, T van Schaik, A Katsarou, ... Clinical Cancer Research 29 (20), 4219-4229, 2023 | | 2023 |
| Locoregional delivery with gene edited and engineered stem cells modulates unique immune profiling in leptomeningeal metastasis N Kanaya, KS Chen, Y Kajiwara, W Seddiq, TA van Schaik, TA Farzani, ... Cancer Research 83 (7_Supplement), 1816-1816, 2023 | | 2023 |
Kok Siong ChenHarvard Medical School, Brigham and Women's HospitalVerified email at bwh.harvard.edu
